Clinical trials
Completed Phase 1/2 Mucopolysaccharidosis II trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
| Green Cross Corporation | 1 |
| JCR Pharmaceuticals Co., Ltd. | 1 |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 1 |
| REGENXBIO Inc. | 1 |
| Shire | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mucopolysaccharidosis II | 7 |
| Sudden Infant Death | 4 |
| Mucopolysaccharidoses | 3 |
| Lysosomal Storage Diseases | 2 |
| Inflammation | 1 |
| Metabolism, Inborn Errors | 1 |
| Mucopolysaccharidosis I | 1 |
| Mucopolysaccharidosis VI | 1 |
| Rare Diseases | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.